Synuclein, alpha (SNCA) (Middle Region) Peptide
SNCA
适用: 人
宿主: 合成
BP, WB
-
- 抗原 See all SNCA products
- SNCA (Synuclein, alpha (SNCA))
- 蛋白结构域
- Middle Region
- 宿主
- 人
-
资源
- 合成
- 应用范围
- Blocking Peptide (BP), Western Blotting (WB)
- 产品特性
- This is a synthetic peptide designed for use in combination with anti-SNCA antibody (Catalog #: ARP42350_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- 纯化方法
- Purified
-
-
- 应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- 浓度
- 1 mg/mL
- 缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
- 注意事项
- Avoid repeated freeze-thaw cycles.
- 储存条件
- -20 °C
- 储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- 抗原
- SNCA (Synuclein, alpha (SNCA))
- 别名
- snca Peptide, MGC64356 Peptide, LOC619283 Peptide, NACP Peptide, alphaSYN Peptide, PARK1 Peptide, PARK4 Peptide, PD1 Peptide, synuclein alpha L homeolog Peptide, alpha-synuclein Peptide, synuclein alpha Peptide, synuclein, alpha Peptide, snca.L Peptide, LOC619283 Peptide, SNCA Peptide, Snca Peptide
- 背景
-
Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease.Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Two alternatively spliced transcripts of SNCA have been identified. Additional splicing may be present but the full-length nature of these variants has not been determined.
Alias Symbols: MGC110988, NACP, PARK1, PARK4, PD1
Protein Interaction Partner: LAMP2,SNCAIP,ADRBK1,APP,BAD,BCL2L1,CALM1,COL25A1,COX3,CSNK1D,CSNK2A1,CSNK2A2,CYCS,ELK1,FGR,FYN,GRK5,GRK6,KLK6,LYN,MAP1B,MAPK1,MAPK8IP1,MAPT,PARK2,PLD1,PRKCE,PTK2B,SLC6A3,SNCAIP,SNCB,SQSTM1,SYK,TH,TOR1A,TUBA1A,UBB,YWHAB,YWHAE,YWHAH,ABZ2,ADRBK1,AIM46,ALB1,APE2,APP,ARL3,ARO1,ATG15,BAD,BAX,CALM1,CDC5,CKI1,COG6,CRH1,DPP1,EMC4,FUN26,FYN,GIP2,GLO4,GRK1,GRK5,GRK6,GTO1,GTT1,HBS1,HRD1,HSP30,INO4,MAD1,MAL31,MAP1B,MAPK1,MAPK3,MAPK8,MAPT,MEI4,MET17,MET32,MSB3,MTC2,MTC3,NAT3,NBP2,NIT2,NPP1,NUP53,OPI3,PARK2,PCA1,PDE2,PEX2,PHO13,PLD1,POX1,PSY3,PTK2,RNY1,RPL41A,SEC14,SEPT2,SEPT4,SLC6A3,SLC6A3,SNCAIP,SNCB,SOD2,SPF1,STF1,STP2,SUV3,SWR1,THI7,THR1,TLG2,TNA1,TOR1A,TSL1,UBC,UBC8,UBP3,VPS24,VPS28,VPS52,VPS60,WAR1,YAT1,YBR284W,YCK3,YCL042W,YCR050C,YCR051W,YDL118W,YFR035C,YGL262W,YGR130C,YGR201C,YJL118W,YKL100C,YKR023W,YPK9
Protein Size: 112 - 分子量
- 11 kDa
- 基因ID
- 6622
- NCBI登录号
- NM_007308, NP_009292
-
You are here:
